Style | Citing Format |
---|---|
MLA | Marsosi V, et al.. "Effects of Sildenafil on Doppler Parameters, Maternal and Neonatal Outcomes in the Active Labor Phase of Low-Risk Pregnancies: A Randomized Clinical Trial." Journal of Perinatal Medicine, vol. 52, no. 2, 2024, pp. 210-214. |
APA | Marsosi V, Haghighi L, Nasimi PH, Ghaemi M, Navaee S (2024). Effects of Sildenafil on Doppler Parameters, Maternal and Neonatal Outcomes in the Active Labor Phase of Low-Risk Pregnancies: A Randomized Clinical Trial. Journal of Perinatal Medicine, 52(2), 210-214. |
Chicago | Marsosi V, Haghighi L, Nasimi PH, Ghaemi M, Navaee S. "Effects of Sildenafil on Doppler Parameters, Maternal and Neonatal Outcomes in the Active Labor Phase of Low-Risk Pregnancies: A Randomized Clinical Trial." Journal of Perinatal Medicine 52, no. 2 (2024): 210-214. |
Harvard | Marsosi V et al. (2024) 'Effects of Sildenafil on Doppler Parameters, Maternal and Neonatal Outcomes in the Active Labor Phase of Low-Risk Pregnancies: A Randomized Clinical Trial', Journal of Perinatal Medicine, 52(2), pp. 210-214. |
Vancouver | Marsosi V, Haghighi L, Nasimi PH, Ghaemi M, Navaee S. Effects of Sildenafil on Doppler Parameters, Maternal and Neonatal Outcomes in the Active Labor Phase of Low-Risk Pregnancies: A Randomized Clinical Trial. Journal of Perinatal Medicine. 2024;52(2):210-214. |
BibTex | @article{ author = {Marsosi V and Haghighi L and Nasimi PH and Ghaemi M and Navaee S}, title = {Effects of Sildenafil on Doppler Parameters, Maternal and Neonatal Outcomes in the Active Labor Phase of Low-Risk Pregnancies: A Randomized Clinical Trial}, journal = {Journal of Perinatal Medicine}, volume = {52}, number = {2}, pages = {210-214}, year = {2024} } |
RIS | TY - JOUR AU - Marsosi V AU - Haghighi L AU - Nasimi PH AU - Ghaemi M AU - Navaee S TI - Effects of Sildenafil on Doppler Parameters, Maternal and Neonatal Outcomes in the Active Labor Phase of Low-Risk Pregnancies: A Randomized Clinical Trial JO - Journal of Perinatal Medicine VL - 52 IS - 2 SP - 210 EP - 214 PY - 2024 ER - |